- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Japanese Paper That Fell For False Stem Cell Claim Takes Corrective Action
30 October 2012 10:55 am
The Japanese newspaper that published what turned out to be false news of the first clinical application of cells derived from induced pluripotent stem cells has detailed the lessons it learned and the steps it is taking to prevent a recurrence. The Yomiuri Shimbun, Japan's largest circulation daily, already apologized to readers for what it admitted were a collection of false articles. Now, in a collection of articles in its 26 October Japanese morning edition and the 27 October English Daily Yomiuri (available online here, here, here, and here), the media organization explained that reporters and editors failed to check basic facts. The newspaper detailed punitive pay cuts for those involved and the replacement of the science news editor.
To head off such problems in the future, the paper pledged to thoroughly check facts, strengthen the verification system in the science news department, and foster the development of reporters who are “able to put matters in perspective."
The Yomiuri also explained that its staff members had failed to check previous statements made by Hisashi Moriguchi, the man at the center of the scandal, that were reported in a number of previously published articles. These included claims of an affiliation with Harvard Medical School and of research accomplishments. This reporting gave Moriguchi, "a false ladder to [the appearance of] academic success," the English language article states.
Several other media organizations that highlighted Moriguchi’s story announced taking similar steps.